山东省公立医疗机构常用口服降糖药可获得性分析

Abstract
Figure/Table
References (16)
Related Citation (0)

Download: PDF (377 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze and evaluate the availability and equipping rate of oral antidiabetic drugs in public medical institutions at all levels in Shandong Province. Methods According to the standardized survey method of World Health Organization / Health Action International (WHO/HAI), the equipping conditions and availability of 7 commonly used oral antidiabetic drugs in 39 public medical institutions of the first, second, third levels in 3 cities of Shandong Province were analyzed and investigated. Results The equipping rate and availability of oral antidiabetic drugs in tertiary hospitals and second-class hospitals were all higher than those in primary health care institutions. The availability of Repaglinide (36.8%) was the highest in original drugs, and the availability of Glipizide (13.4%) was the lowest, the original drugs of Glibenclamide couldn′t be obtained. The availability of Metformin was the highest (86.8%) in generic drugs, and the availability of Glibenclamide was the lowest (5.3%). In tertiary hospitals, original drugs (77.8%) had higher equipping rate than generic drugs (57.1%). In primary medical institutions, original drugs (8.6%) had lower equipping rate than generic drugs (43.3%), and the equipping rates of both of them were lower. Conclusion The availability and equipping rate of oral antidiabetic drugs in general hospitals in Shandong Province are all higher, which in primary health care institutions are all lower. In order to meet the medical needs of diabetic patients, it is necessary to take various measures to improve the availability of oral antidiabetic drugs in primary health care institutions and the quality of generic drugs.

Key words： Oral antidiabetic drugs Availability Public hospitals Shandong Province

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEN Nan SONG Yan

Cite this article:

WEN Nan SONG Yan. Analysis of the availability of oral antidiabetic drugs in public medical institutions in Shandong Province[J]. 中国医药导报, 2019, 16(14): 136-139.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I14/136

[1] National Health and Family Planning Commission of the People′s Republic of China. Win the Battle of Obesity to Prevent Diabetes [EB/OL].（2011-09-29）. http：//moh.gov.cn/publicfiles/business/htmlfiles/wsh/pzcjd/200804/21263.html
[2] 陈友兰，唐国宝.2004年厦门市思明区糖尿病患者卫生服务利用现况调查[J].实用预防医学，2006，13（1）：111-115.
[3] WHO/HAI. Measuring Medicine Prices，Availability，Affordability and Price Components [M]. 2nd ed. Geneva：World Health Organization，2008：5.
[4] 阳昊.湖北省农村地区县乡两级基本药物可获得性研究[D].武汉：华中科技大学出版社，2009.
[5] 管晓东，信枭雄，刘洋，等.我国基本药物可获得性评价实证研究[J].中国药房，2013，24（24）：2216-2219.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）[J].中国糖尿病杂志，2014，22（8）：2-42.
[7] 中华人民共和国国家卫生和计划生育委员会.关于印发《国家基本药物临床应用指南》和《国家基本药物处方集》的通知[EB/OL].[2015-09-15]. http：//www.nhfpc.gov.cn/mohywzc/s3586/201005/47420.shtml
[8] 姜明欢，王乐，王文娟，等.陕西省公立医院和零售药店基本药物价格及可获得性比较研究[J].中国药房，2013， 24（4）：308-313.
[9] 朱稳稳，杨才君，蔡文芳，等.陕西省公立医院口服降糖药可获得性评价研究[J].中国药房，2017，28（5）：596-598.
[10] 姜明欢，王乐，王文娟，等.基于WHO/HAI标准化调查法对陕西省慢性病用药价格与供应情况的调查分析[J].中国药房，2013，24（28）：2598-2601.
[11] 母义明，纪立农，宁光，等.二甲双胍临床应用专家共识（2016年版）[J].中国糖尿病杂志，2016，24（10）：871-884.
[12] 陈守奎.常用口服降糖药分类及评价[J].医药导报，2016， 35（Z1）：79-81.
[13] 许日祥，解雪峰，李姝婷，等.基层医疗卫生机构药品供应现状及短缺因素分析-以安徽省为例[J].中国卫生政策研究，2018，11（3）：78-82.
[14] 李峰.广州市社区卫生服务机构基本药物可获得性研究[D].广州：广州中医药大学，2011：34-35.
[15] 谢沐风.对国务院《关于印发国家药品安全十二五规划通知》的解读与思考[J].药品评价，2012，9（20）：6-10.
[16] 王亮，李爱花，岳晓萌，等.日本药品价格制度研究及对我国药品价格管理的启示[J].中国卫生经济，2017，36（10）：87-91.